论文部分内容阅读
目的:探究多潘立酮联合法莫替丁治疗小儿消化功能紊乱的临床疗效。方法:选择我院于2013年5月-2014年8月接收的150例小儿消化紊乱患者作为研究对象,将其随机分为实验组和对照组,每组平均75例,对照组患儿接受多潘立酮单药治疗,实验组患者接受潘立酮联合莫替丁治疗,分析两组患者的临床疗效。结果:经过相应的对症治疗,两组患儿的恶心呕吐、上腹不适等症状得以改善。实验组腹泻、便秘、腹痛患儿的临床治疗总有效率均明显高于对照组患儿(P<0.05),实验组患儿的临床治疗起效时间为(9.5±2.2)d,明显短于对照组患儿(13.1±3.2)d(P<0.05)。结论:多潘立酮联合法莫替丁对小儿消化功能紊乱的临床疗效显著,无明显不良反应且药效快。
Objective: To investigate the clinical efficacy of domperidone combined with famotidine in treating digestive disorders in children. Methods: A total of 150 cases of pediatric digestive disorders received in our hospital from May 2013 to August 2014 were selected as study subjects. They were randomly divided into experimental group and control group, with an average of 75 cases in each group. Patients in control group received domperidone Monotherapy, patients in the experimental group were treated with the combination of paltin and montetin, and the clinical efficacy of the two groups was analyzed. Results: After the corresponding symptomatic treatment, two groups of children with nausea and vomiting, abdominal discomfort and other symptoms can be improved. The total effective rate of clinical treatment in children with diarrhea, constipation and abdominal pain in the experimental group were significantly higher than those in the control group (P <0.05). The onset time of clinical treatment in the experimental group was (9.5 ± 2.2) d, significantly shorter than Control children (13.1 ± 3.2) d (P <0.05). Conclusion: The clinical efficacy of domperidone and famotidine in children with digestive disorders is significant, no obvious adverse reactions and fast efficacy.